CERES INC. Logo

CERES INC.

Develops online media platforms connecting consumers with advertisers through a rewards system.

3696 | T

Overview

Corporate Details

ISIN(s):
JP3423570005
LEI:
Country:
Japan
Address:
渋谷区桜丘町1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ceres Inc. is an internet marketing company operating under the mission of "Enriching the world through internet marketing." The company's core business involves the development and management of online media platforms. Its flagship service is "Moppy," a point media site where users can accumulate points through various online activities and exchange them for rewards. By connecting a large consumer base with advertisers, Ceres provides marketing and user acquisition solutions for businesses while offering value to its platform users.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 05:30
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-08-13 05:29
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 228.9 KB
2025-07-18 08:49
M&A Activity
臨時報告書
Japanese 22.5 KB
2025-07-01 08:56
Major Shareholding Notification
大量保有報告書
Japanese 34.4 KB
2025-05-08 09:40
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2025-04-21 09:17
Share Issue/Capital Change
臨時報告書
Japanese 30.8 KB
2025-03-26 06:24
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.2 KB
2025-03-26 06:18
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 06:10
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-03-26 05:15
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 18.0 KB
2025-01-27 09:12
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2024-08-13 08:58
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-08-13 08:57
Interim Report
半期報告書-第20期(2024/01/01-2024/12/31)
Japanese 197.3 KB

Automate Your Workflow. Get a real-time feed of all CERES INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CERES INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CERES INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bestone.Com Co.,Ltd Logo
An online travel agency specializing in domestic and overseas cruise tours and tickets.
Japan
6577
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America
BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America
BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea
251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France
ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium
BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain
BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea
086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America
BOLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.